Skip to content
★ Sign in to follow
JF

Jill F. Schiaparelli

Executive
Total declarations
7
Company
1
▲ Purchases (7 ops.)
€27k
▼ Sales (0 ops.)
—

Latest filing published 22 May 2014 for Axogen, Inc., €3,838.

Insider track record

Disclosed buys
7
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
7
Positive at T+90
100%
Median T+90
+32.7%

Based on 7 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 22 May 2014 · 4554 days ago · €3,838
    +24.3%
    Entry US$2.51 · Close at T+365 US$3.12
  • Filed 16 Aug 2013 · 4833 days ago · €11k
    -23.0%
    Entry US$3.00 · Close at T+365 US$2.31
  • Filed 06 Dec 2012 · 5086 days ago · €3,924
    +66.4%
    Entry US$2.35 · Close at T+365 US$3.91
  • Filed 03 Dec 2012 · 5089 days ago · €2,084
    +51.9%
    Entry US$2.60 · Close at T+365 US$3.95
  • Filed 16 Nov 2012 · 5106 days ago · €1,570
    +49.8%
    Entry US$2.75 · Close at T+365 US$4.12

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Jill F. Schiaparelli: trading record in brief

All filings by Jill F. Schiaparelli on record concern Axogen, Inc. In total, 7 filings cover trades dated from 14 November 2012 to 20 May 2014.

Purchases make up the whole of the open-market record (7 purchases, €27k). Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2014, the count stands at 1 purchase and no sales.

In size, the median ticket on the buying side is €2,084. After 7 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +32.7%. This is a record of the past, not a forecast.

The newest entry dates from 22 May 2014: an open-market purchase of €3,838, in Axogen, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jill F. Schiaparelli

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    SVP, Bus. Strategy&MarketingExecutivesAxogen, Inc.
    5,260 USD0SEC
    2,000 shares@ US$2.63Common StockSEC:0001209191-14-036320:0
    Canonical exit: 18 Aug 2014 (T+90)
  • ▲
    SVP, Bus. Strategy&MarketingExecutivesAxogen, Inc.
    15,000 USD0SEC
    5,000 shares@ US$3.00Common StockSEC:0001209191-13-041097:0
    Canonical exit: 12 Nov 2013 (T+90)
  • ▲
    SVP, Bus. Strategy&MarketingExecutivesAxogen, Inc.
    5,100 USD0SEC
    2,000 shares@ US$2.55Common StockSEC:0001209191-12-056050:0
    Canonical exit: 4 Mar 2013 (T+90)
  • ▲
    SVP, Bus. Strategy&MarketingExecutivesAxogen, Inc.
    2,700 USD0SEC
    1,000 shares@ US$2.70Common StockSEC:0001209191-12-055332:0
    Canonical exit: 27 Feb 2013 (T+90)
  • ▲
    SVP, Bus. Strategy&MarketingExecutivesAxogen, Inc.
    1,995 USD0SEC
    750 shares@ US$2.66Common StockSEC:0001209191-12-053479:0
    Canonical exit: 12 Feb 2013 (T+90)
  • ▲
    SVP, Bus. Strategy&MarketingExecutivesAxogen, Inc.
    2,540 USD0SEC
    1,000 shares@ US$2.54Common StockSEC:0001209191-12-053479:1
    Canonical exit: 13 Feb 2013 (T+90)
  • ▲
    SVP, Bus. Strategy&MarketingExecutivesAxogen, Inc.
    2,500 USD0SEC
    1,000 shares@ US$2.50Common StockSEC:0001209191-12-053479:2
    Canonical exit: 13 Feb 2013 (T+90)

7 of 7 declarations